These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 20421047

  • 1. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.
    Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, Doan HQ, Weiss HL, Evers BM.
    J Am Coll Surg; 2010 May; 210(5):767-76, 776-8. PubMed ID: 20421047
    [Abstract] [Full Text] [Related]

  • 2. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 3. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
    Faghiri Z, Bazan NG.
    Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 5. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.
    Wang H, Duan L, Zou Z, Li H, Yuan S, Chen X, Zhang Y, Li X, Sun H, Zha H, Zhang Y, Zhou L.
    Int J Med Sci; 2014 Jun; 11(8):841-9. PubMed ID: 24936148
    [Abstract] [Full Text] [Related]

  • 6. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X, Kambe F, Moeller LC, Refetoff S, Seo H.
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.
    Tasioudi KE, Sakellariou S, Levidou G, Theodorou D, Michalopoulos NV, Patsouris E, Korkolopoulou P, Saetta AA.
    APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437
    [Abstract] [Full Text] [Related]

  • 8. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.
    Minhajuddin M, Bijli KM, Fazal F, Sassano A, Nakayama KI, Hay N, Platanias LC, Rahman A.
    J Biol Chem; 2009 Feb 13; 284(7):4052-61. PubMed ID: 19074768
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M.
    Br J Dermatol; 2009 Aug 13; 161(2):357-63. PubMed ID: 19438435
    [Abstract] [Full Text] [Related]

  • 10. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.
    Matheny RW, Adamo ML.
    Biochem Biophys Res Commun; 2009 Dec 11; 390(2):252-7. PubMed ID: 19799871
    [Abstract] [Full Text] [Related]

  • 11. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA, Levidou G, Saetta AA, Chatziandreou I, Tomos P, Thalassinos N, Anastasiou N, Spartalis E, Kavantzas N, Patsouris E, Korkolopoulou P.
    Oncol Rep; 2013 Aug 11; 30(2):623-36. PubMed ID: 23728071
    [Abstract] [Full Text] [Related]

  • 12. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 Aug 11; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 13. Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat.
    Katta A, Kakarla S, Wu M, Paturi S, Gadde MK, Arvapalli R, Kolli M, Rice KM, Blough ER.
    Exp Diabetes Res; 2009 Aug 11; 2009():384683. PubMed ID: 20368999
    [Abstract] [Full Text] [Related]

  • 14. Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer.
    Gulhati P, Cai Q, Li J, Liu J, Rychahou PG, Qiu S, Lee EY, Silva SR, Bowen KA, Gao T, Evers BM.
    Clin Cancer Res; 2009 Dec 01; 15(23):7207-16. PubMed ID: 19934294
    [Abstract] [Full Text] [Related]

  • 15. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
    Xu G, Zhang W, Bertram P, Zheng XF, McLeod H.
    Int J Oncol; 2004 Apr 01; 24(4):893-900. PubMed ID: 15010827
    [Abstract] [Full Text] [Related]

  • 16. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
    Li JF, Li GD, Gu L, Liu WP, Li FY, Liao DY, Ma ZG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct 01; 29(10):649-53. PubMed ID: 19176054
    [Abstract] [Full Text] [Related]

  • 17. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2010 Jan 01; 51(1):421-9. PubMed ID: 19661225
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
    Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G.
    BMC Cancer; 2010 Apr 27; 10():161. PubMed ID: 20423485
    [Abstract] [Full Text] [Related]

  • 19. Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.
    Liontos M, Trigka EA, Korkolopoulou P, Tzannis K, Lainakis G, Koutsoukos K, Kostouros E, Lykka M, Papandreou CN, Karavasilis V, Christodoulou C, Papatsoris A, Skolarikos A, Varkarakis I, Adamakis I, Alamanis C, Stravodimos K, Mitropoulos D, Deliveliotis C, Constantinidis CA, Saetta A, Patsouris E, Dimopoulos MΑ, Bamias A.
    World J Urol; 2017 Mar 27; 35(3):411-419. PubMed ID: 27395374
    [Abstract] [Full Text] [Related]

  • 20. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N, Flynn DC, Zhang Z, Zhong XS, Walker V, Liu KJ, Shi X, Jiang BH.
    Am J Physiol Cell Physiol; 2004 Aug 27; 287(2):C281-91. PubMed ID: 15028555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.